Breast Cancer: Coordinated Regulation of CCL2 Secretion by Intracellular Glycosaminoglycans and Chemokine Motifs

Breast Cancer: Coordinated Regulation of CCL2 Secretion by Intracellular Glycosaminoglycans and Chemokine Motifs

The chemokine CCL2 (MCP-1) has been identified as a prominent tumor-promoting factor in breast cancer. The major source for CCL2 is in the tumor cells; thus, identifying the mechanisms regulating CCL2 release by these cells may enable the future design of modalities inhibiting CCL2 secretion and co...

Full description

Bibliographic Details
Main Authors:	Yaeli Lebel-Haziv, Tsipi Meshel, Gali Soria, Adva Yeheskel, Elad Mamon, Adit Ben-Baruch
Format:	Article
Language:	English
Published:	Elsevier 2014-09-01
Series:	Neoplasia: An International Journal for Oncology Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1476558614001109

Similar Items

Mechanisms Regulating the Secretion of the Promalignancy Chemokine CCL5 by Breast Tumor Cells: CCL5's 40s Loop and Intracellular Glycosaminoglycans
by: Gali Soria, et al.
Published: (2012-01-01)

Epidermal Growth Factor and Estrogen Act by Independent Pathways to Additively Promote the Release of the Angiogenic Chemokine CXCL8 by Breast Tumor Cells
by: Karin Haim, et al.
Published: (2011-03-01)

Structural Evidence for the Tetrameric Assembly of Chemokine CCL11 and the Glycosaminoglycan Arixtra™
by: Julie A. Leary, et al.
Published: (2013-11-01)

Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition
by: Shabtai Esther, et al.
Published: (2011-04-01)

Tumor-Promoting Circuits That Regulate a Cancer-Related Chemokine Cluster: Dominance of Inflammatory Mediators Over Oncogenic Alterations
by: Adit Ben-Baruch, et al.
Published: (2012-01-01)

Chemokines and glycosaminoglycans
by: Amanda E.I. Proudfoot
Published: (2015-05-01)

Interference with oligomerization and glycosaminoglycan binding of the chemokine CCL5 improves experimental liver injury.
by: Andreas Nellen, et al.
Published: (2012-01-01)

Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer
by: Yulia Liubomirski, et al.
Published: (2019-04-01)

Regulation of circulating chemokine concentrations and bioactivity by glycosaminoglycans and chemokine binding proteins
by: Topping, Joanna Ruth
Published: (2003)

Targeting Chemokine—Glycosaminoglycan Interactions to Inhibit Inflammation
by: Helena Crijns, et al.
Published: (2020-03-01)

Progression of Luminal Breast Tumors Is Promoted by Ménage à Trois between the Inflammatory Cytokine TNFα and the Hormonal and Growth-Supporting Arms of the Tumor Microenvironment
by: Polina Weitzenfeld, et al.
Published: (2013-01-01)

Inflammatory Factors of the Tumor Microenvironment Induce Plasticity in Nontransformed Breast Epithelial Cells: EMT, Invasion, and Collapse of Normally Organized Breast Textures
by: Tal Leibovich-Rivkin, et al.
Published: (2013-12-01)

Nucleotides Regulate Secretion of the Inflammatory Chemokine CCL2 from Human Macrophages and Monocytes
by: K. R. Higgins, et al.
Published: (2014-01-01)

The activity of CCL18 is principally mediated through interaction with glycosaminoglycans
by: Sonja C. Krohn, et al.
Published: (2013-07-01)

The role of glycosaminoglycan binding and oligomerisation for chemokine function in vivo
by: Johnson, ZoeÌˆ
Published: (2003)

Murine Placental Erythroid Cells Are Mainly Represented by CD45+ Immunosuppressive Erythroid Cells and Secrete CXCL1, CCL2, CCL3 and CCL4 Chemokines
by: Alrhmoun, S., et al.
Published: (2023)

Does C-C Motif Chemokine Ligand 2 (CCL2) Link Obesity to a Pro-Inflammatory State?
by: Sebastian Dommel, et al.
Published: (2021-02-01)

Variants of C-C motif chemokine 22 (CCL22) are associated with susceptibility to atopic dermatitis: case-control studies.
by: Tomomitsu Hirota, et al.
Published: (2011-01-01)

Chemokine (C-C motif) ligand 2 (CCL2) in sera of patients with type 1 diabetes and diabetic complications.
by: Ruili Guan, et al.
Published: (2011-04-01)

Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System
by: Amanda E. I. Proudfoot, et al.
Published: (2017-08-01)

Examination of MCP chemokine signal transduction mechanisms and glycosaminoglycan interactions
by: Wain, Julie H.
Published: (2002)

Blockade of breast cancer metastasis by disruption of chemokine/glycosaminoglycan interactions
by: Harvey, James R.
Published: (2005)

Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy
by: Dina Morein, et al.
Published: (2020-06-01)

The Specific Role of CCL8 Chemokine in Atherosclerosis
by: Yulduz Yusupbaevna Baltaeva, et al.
Published: (2021-06-01)

The Inflammatory Chemokine CCL5 and Cancer Progression
by: Donatella Aldinucci, et al.
Published: (2014-01-01)

Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis
by: Yamaguchi Kazuhiro, et al.
Published: (2009-08-01)

Chemokine/chemokine receptor pair CCL20/CCR6 in intestinal immunity
by: Ya-Lin Lin, et al.
Published: (2017)

The Intricate Expression of CC Chemokines in Glial Tumors: Evidence for Involvement of CCL2 and CCL5 but Not CCL11
by: Mozhgan Moogooei, et al.
Published: (2015-12-01)

Inhibition of chemokine (C-C motif) receptor 7 sialylation suppresses CCL19-stimulated proliferation, invasion and anti-anoikis.
by: Mei-Lin Su, et al.
Published: (2014-01-01)

Multifaceted roles of CCL20 (C-C motif chemokine ligand 20): mechanisms and communication networks in breast cancer progression
by: Louis Boafo Kwantwi, et al.
Published: (2021-01-01)

External validation of urinary C–C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury
by: Sean M. Bagshaw, et al.
Published: (2021-05-01)

Neuronal CC chemokines: the distinct roles of CCL21 and CCL2 in neuropathic pain
by: Knut eBiber, et al.
Published: (2014-08-01)

The influence of the chemokine CCL22 on tumor development and growth
by: Rapp, Moritz
Published: (2013)

Adipose-specific C-C motif chemokine ligand (CCL) 19 overexpression drives the mice to both insulin resistance and weight gain
by: Yuki Nishimura, et al.
Published: (2021-08-01)

Effect of Chemokine (C-C Motif) Ligand 7 (CCL7) and Its Receptor (CCR2) Expression on Colorectal Cancer Behaviors
by: Ewa Kurzejamska, et al.
Published: (2019-02-01)

The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity
by: Stefanie Scheu, et al.
Published: (2017-11-01)

CCL18 exhibits a regulatory role through inhibition of receptor and glycosaminoglycan binding.
by: Sonja C Krohn, et al.
Published: (2013-01-01)

Chemokines (CCL3, CCL4, and CCL5) Inhibit ATP-Induced Release of IL-1β by Monocytic Cells
by: Anca-Laura Amati, et al.
Published: (2017-01-01)

Higher expression of CCL2, CCL4, CCL5, CCL21, and CXCL8 chemokines in the skin associated with parasite density in canine visceral leishmaniasis.
by: Daniel Menezes-Souza, et al.
Published: (2012-01-01)

The relationship between chemokines CCL2, CCL3, and CCL4 with the tumor microenvironment and tumor-associated macrophage markers in colorectal cancer
by: Marjorie De la Fuente López, et al.
Published: (2018-11-01)